• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problem Activation, Positioning or Separation Problem (2906)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/02/2024
Event Type  malfunction  
Event Description
It was reported that the stent partially deployed.An eluvia drug-eluting vascular stent system was selected for use.The target lesion was located in the superficial femoral artery and was reported to be 100% stenosed with moderate tortuosity and severe calcification.The target lesion was predilated prior to advancing the eluvia delivery system.When deployment of the eluvia stent was attempted, the stent partially deployed before failing to deploy fully.The eluvia system was removed and replaced with another eluvia system.The procedure was completed, and there were no reported patient injuries.
 
Event Description
It was reported that the stent partially deployed.An eluvia drug-eluting vascular stent system was selected for use.The target lesion was located in the superficial femoral artery and was reported to be 100% stenosed with moderate tortuosity and severe calcification.The target lesion was predilated prior to advancing the eluvia delivery system.When deployment of the eluvia stent was attempted, the stent partially deployed before failing to deploy fully.The eluvia system was removed and replaced with another eluvia system.The procedure was completed, and there were no reported patient injuries.It was further reported that the guidewire used in conjunction with the eluvia system was a non-boston scientific 0.035 guidewire.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18798593
MDR Text Key337531171
Report Number2124215-2024-11655
Device Sequence Number1
Product Code NIU
Combination Product (y/n)Y
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number24653
Device Catalogue Number24653
Device Lot Number0032876866
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/05/2024
Initial Date FDA Received02/28/2024
Supplement Dates Manufacturer Received03/05/2024
Supplement Dates FDA Received03/19/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/04/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-